Preparation of Dual-Drug-Loaded Liver-Targeted Liposomes Co-Modifiedwith SP94 Peptide and TAT Peptide
SP94/TAT-DOX/DTX-LPs achieved effective dual-stage targeting and synergistic cytotoxicity. High encapsulation, stability, and sustained release support their potential as a targeted platform for liver cancer therapy, reducing off-target toxicity.
Authors
- Ye Gan (ORCID: https://orcid.org/0000-0002-0425-2921)
- Haotian Wu (ORCID: https://orcid.org/0000-0003-0729-2619)
- Jiankai Zhang (ORCID: https://orcid.org/0000-0002-8491-0225)
- Lili Li (ORCID: https://orcid.org/0000-0002-0292-5889)
- Xu Liu (ORCID: https://orcid.org/0000-0002-8932-4989)
- Jing Lin (ORCID: https://orcid.org/0000-0002-4199-3980)
- Simei Luo
- Mingqing Yuan
Institutions
- Guangxi University (CN)
- Buchang Pharma (China) (CN)
Publication Details
- Journal
- Current Drug Delivery
- Published
- 2026-01-08
- DOI
- https://doi.org/10.2174/0115672018371655251022113914
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00